R — Class II drug recall D-0113-2026
Ongoing recall by QuVa Pharma, Inc., reported 2025-11-05, distributed nationwide. Presence of Particulate Matter
| Recall number | D-0113-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | QuVa Pharma, Inc., Sugar Land, TX, United States |
| Recall initiated | 2025-10-10 |
| Classified | 2025-10-27 |
| Reported by FDA | 2025-11-05 |
| Distributed | Nationwide (US) |
| Quantity | 75,885 syringes |
| Reason classes | specification failure |
| NDC | 70092-1433-50 |
| Lot numbers | 10149179, 10149503, 10149504, 10149657, 10149658, 10149659, 10149729, 10149730, 10149732, 10149733, 10149737, 10149738, 10149787, 10149788, 10149790, 10149791, 10149792, 10149800, 10149833, 10149838, 10149839, 10149840, 10149841, 10149842, 10149843, 10149968, 10149969, 10150007, 10150134, 10150135, 10150137, 10150138, 10150139, 10150140, 10150182, 10150183, 10150184, 10150185, 10150186, 10150187 and 199 more |
| Expiration dates | 2025-10-13, 2025-10-15, 2025-10-16, 2025-10-17, 2025-10-19, 2025-10-20, 2025-10-21, 2025-10-22, 2025-10-23, 2025-10-24, 2025-10-26, 2025-10-27, 2025-10-28, 2025-10-29, 2025-10-30, 2025-10-31, 2025-11-03, 2025-11-04, 2025-11-05, 2025-11-06, 2025-11-09, 2025-11-10, 2025-11-11, 2025-11-12, 2025-11-13 and 23 more |
Product
R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50
Reason for recall
Presence of Particulate Matter
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0113-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.